Condition: Hodgkin Lymphoma · Sponsor: Canadian Cancer Trials Group
This study is being done to determine if two new drugs can shrink or eliminate classical Hodgkins lymphoma.
This description comes directly from the study's public registry record.
Annette Hay · 613-533-6430 · ahay@ctg.queensu.ca
Lois Shepherd · 613-533-6430 · lshepherd@ctg.queensu.ca
Always discuss trial participation with your own doctor first.
| Concord Repatriation General Hospital | Concord, New South Wales, Australia | Recruiting |
| Shoalhaven Cancer Care Centre | Nowra, New South Wales, Australia | Recruiting |
| Wollongong Hospital | Wollongong, New South Wales, Australia | Recruiting |
| Royal Adelaide Hospital | Adelaide, South Australia, Australia | Recruiting |
| Austin Hospital | Heidelberg, Victoria, Australia | Recruiting |
| Sir Charles Gairdner Hospital | Perth, Western Australia, Australia | Recruiting |
| Arthur J.E. Child Comprehensive Cancer Centre | Calgary, Alberta, Canada | Recruiting |
| BCCA - Vancouver | Vancouver, British Columbia, Canada | Recruiting |
| Dr. H. Bliss Murphy Cancer Centre | St. John's, Newfoundland and Labrador, Canada | Recruiting |
| QEII Health Sciences Centre | Halifax, Nova Scotia, Canada | Recruiting |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton, Ontario, Canada | Recruiting |
| London Health Sciences Centre Research Inc. | London, Ontario, Canada | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05180097